Danaher wins conditional clearance for $21 billion GE BioPharma deal
Danaher’s takeover of GE’s BioPharma business has been approved by EU merger control authorities, conditional on the divestment of five Danaher businesses. The final sale of these businesses is conditional upon the...To view the full article, register now.
Already a subscriber? Click here to view full article